VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 160 filers reported holding VANDA PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is 12.90 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $532,546 | +370.8% | 94,256 | +242.5% | 0.00% | – |
Q1 2024 | $113,107 | +947.8% | 27,520 | +975.8% | 0.00% | – |
Q4 2023 | $10,795 | +24.8% | 2,558 | +27.7% | 0.00% | – |
Q3 2023 | $8,653 | +1213.1% | 2,003 | +1903.0% | 0.00% | – |
Q2 2023 | $659 | -2.9% | 100 | 0.0% | 0.00% | – |
Q1 2023 | $679 | -96.2% | 100 | -93.8% | 0.00% | – |
Q1 2022 | $18,000 | -91.7% | 1,624 | -88.3% | 0.00% | – |
Q4 2021 | $218,000 | +581.2% | 13,880 | +653.1% | 0.00% | – |
Q3 2021 | $32,000 | -87.8% | 1,843 | -84.9% | 0.00% | – |
Q2 2021 | $262,000 | +2520.0% | 12,167 | +1813.1% | 0.00% | – |
Q1 2021 | $10,000 | -78.3% | 636 | -81.9% | 0.00% | – |
Q4 2020 | $46,000 | -11.5% | 3,522 | -34.8% | 0.00% | – |
Q3 2020 | $52,000 | +5100.0% | 5,404 | +5096.2% | 0.00% | – |
Q2 2020 | $1,000 | -91.7% | 104 | -85.9% | 0.00% | – |
Q4 2019 | $12,000 | +50.0% | 740 | +19.4% | 0.00% | – |
Q3 2019 | $8,000 | -95.2% | 620 | -91.5% | 0.00% | -100.0% |
Q3 2018 | $168,000 | +354.1% | 7,331 | +197.9% | 0.00% | – |
Q4 2017 | $37,000 | -63.0% | 2,461 | -60.7% | 0.00% | -100.0% |
Q4 2016 | $100,000 | -90.4% | 6,255 | -90.0% | 0.00% | -90.9% |
Q3 2016 | $1,045,000 | +1641.7% | 62,772 | +777.9% | 0.01% | +1000.0% |
Q1 2016 | $60,000 | -75.0% | 7,150 | -72.3% | 0.00% | -66.7% |
Q4 2015 | $240,000 | -57.7% | 25,818 | -48.6% | 0.00% | -62.5% |
Q3 2015 | $567,000 | +51.6% | 50,236 | +70.5% | 0.01% | +60.0% |
Q2 2015 | $374,000 | -24.6% | 29,468 | -44.8% | 0.01% | -37.5% |
Q1 2015 | $496,000 | -40.8% | 53,348 | -8.9% | 0.01% | -38.5% |
Q4 2014 | $838,000 | +91.8% | 58,544 | +39.2% | 0.01% | +85.7% |
Q3 2014 | $437,000 | +19.4% | 42,061 | +86.2% | 0.01% | +16.7% |
Q2 2014 | $366,000 | -83.7% | 22,591 | -83.7% | 0.01% | -84.2% |
Q1 2014 | $2,251,000 | -18.0% | 138,549 | -37.4% | 0.04% | -7.3% |
Q4 2013 | $2,745,000 | +226.0% | 221,182 | +188.1% | 0.04% | +156.2% |
Q3 2013 | $842,000 | -30.7% | 76,785 | -48.9% | 0.02% | -46.7% |
Q2 2013 | $1,215,000 | – | 150,320 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Palo Alto Investors LP | 4,525,476 | $74,263,000 | 4.09% |
ARMISTICE CAPITAL, LLC | 2,828,000 | $46,407,000 | 2.68% |
Birchview Capital, LP | 80,000 | $1,313,000 | 0.95% |
GLOBEFLEX CAPITAL L P | 145,426 | $2,386,000 | 0.45% |
BOGLE INVESTMENT MANAGEMENT L P /DE/ | 231,733 | $3,803,000 | 0.36% |
361 CAPITAL LLC | 77,630 | $1,274,000 | 0.35% |
CADENCE CAPITAL MANAGEMENT LLC | 152,428 | $2,501,000 | 0.27% |
BOOTHBAY FUND MANAGEMENT, LLC | 148,000 | $2,429,000 | 0.21% |
EMERALD ADVISERS, LLC | 258,497 | $4,242,000 | 0.18% |
EMERALD MUTUAL FUND ADVISERS TRUST | 251,730 | $4,131,000 | 0.17% |